18.55  0.53 (2.94%)		07-26 16:00
Open: 18.39 High: 18.9 Volume: 122,858		Pre. Close: 18.02 Low: 17.67 Market Cap: 601(M)

Short term
Mid term
Targets	6-month :	22.07	1-year :	25.78
Resists	First :	18.89	Second :	22.07
Pivot price	17.29
Supports	First :	16.97	Second :	15.78
MAs	MA(5) :	17.74	MA(20) :	17.15
	MA(100) :	14.89	MA(250) :	10.2
MACD	MACD :	0.3	Signal :	0.2
%K %D	K(14,3) :	74.8	D(3) :	65.3
RSI	RSI(14): 60.5
52-week	High :	18.89	Low :	3.72

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ PEPG ] has closed Bollinger Bands are 32.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	18.92 - 18.99	18.99 - 19.05
Low:	17.49 - 17.57	17.57 - 17.64
Close:	18.42 - 18.55	18.55 - 18.66

PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is also developing PGN-EDODM1, an EDO peptide-conjugated PMO for the treatment of myotonic dystrophy type 1, as well as EDO therapeutic candidates, such as PGN-EDO53, PGN-EDO45, and PGN-EDO44 for the treatment of DMD. The company was founded in 2018 and is headquartered in Cambridge, Massachusetts.

Fri, 26 Jul 2024
PepGen (NASDAQ:PEPG) Reaches New 12-Month High at $18.90 - MarketBeat

Sat, 20 Jul 2024
PepGen Inc. (NASDAQ:PEPG) Insider Michelle L. Mellion Sells 12,625 Shares of Stock - Defense World

Sat, 20 Jul 2024
PepGen Inc. (NASDAQ:PEPG) Insider Michelle L. Mellion Sells 12,625 Shares - American Banking and Market News

Fri, 19 Jul 2024
PepGen Inc. (NASDAQ:PEPG) Insider Michelle L. Mellion Sells 12,625 Shares - MarketBeat

Wed, 17 Jul 2024
PepGen Inc. (NASDAQ:PEPG) Insider Michelle L. Mellion Sells 5,901 Shares of Stock - Defense World

Wed, 17 Jul 2024
PepGen Inc. (NASDAQ:PEPG) Insider Michelle L. Mellion Sells 3,288 Shares - Defense World

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares Out	32 (M)
Shares Float	17 (M)
Held by Insiders	0 (%)
Held by Institutions	91 (%)
Shares Short	380 (K)
Shares Short P.Month	394 (K)

EPS	-3.25
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	5.53
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	-26.6 %
Return on Equity (ttm)	-46.8 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	-2.63
Qtrly Earnings Growth	0 %
Operating Cash Flow	-76 (M)
Levered Free Cash Flow	-52 (M)

PE Ratio	-5.73
PEG Ratio	0
Price to Book value	3.35
Price to Sales	0
Price to Cash Flow	-7.91

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.